ADHD Market Hurt By Safety Concerns, Lilly Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Strattera marketer says that label change and withdrawal of Shire's Adderall XR in Canada has slowed the growth of the attention deficit/hyperactivity disorder market. Lilly will focus on consumers with new DTC ad designed to encourage adult patients to seek treatment.